Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionBispecific mAb targeting nerve growth factor (NGF) and tumor necrosis factor (TNF)
Molecular Target Nerve growth factor (NGF) ; Tumor necrosis factor (TNF)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat osteoarthritis (OA) knee pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today